NO177714C - Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater

Info

Publication number
NO177714C
NO177714C NO891389A NO891389A NO177714C NO 177714 C NO177714 C NO 177714C NO 891389 A NO891389 A NO 891389A NO 891389 A NO891389 A NO 891389A NO 177714 C NO177714 C NO 177714C
Authority
NO
Norway
Prior art keywords
therapeutically active
active peptide
peptide derivatives
analogous process
preparing therapeutically
Prior art date
Application number
NO891389A
Other languages
English (en)
Norwegian (no)
Other versions
NO177714B (no
NO891389L (no
NO891389D0 (no
Inventor
Tohru Kino
Motoaki Nishikawa
Masami Ezaki
Sumio Kiyoto
Masakuni Okuhara
Shigehiro Takase
Satoshi Okada
Nobuharu Shigematsu
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO891389D0 publication Critical patent/NO891389D0/no
Publication of NO891389L publication Critical patent/NO891389L/no
Publication of NO177714B publication Critical patent/NO177714B/no
Publication of NO177714C publication Critical patent/NO177714C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO891389A 1988-04-05 1989-04-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater NO177714C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807921A GB8807921D0 (en) 1988-04-05 1988-04-05 Ws-9326 & its derivatives

Publications (4)

Publication Number Publication Date
NO891389D0 NO891389D0 (no) 1989-04-03
NO891389L NO891389L (no) 1989-10-06
NO177714B NO177714B (no) 1995-07-31
NO177714C true NO177714C (no) 1995-11-08

Family

ID=10634574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891389A NO177714C (no) 1988-04-05 1989-04-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater

Country Status (20)

Country Link
EP (1) EP0336230B1 (fr)
JP (1) JP2551142B2 (fr)
KR (1) KR0132567B1 (fr)
CN (1) CN1037857C (fr)
AT (1) ATE148890T1 (fr)
AU (1) AU627453B2 (fr)
CA (1) CA1335662C (fr)
DE (1) DE68927759T2 (fr)
DK (1) DK161789A (fr)
ES (1) ES2097736T3 (fr)
FI (1) FI102547B (fr)
GB (1) GB8807921D0 (fr)
GR (1) GR3023353T3 (fr)
HU (1) HU204853B (fr)
IL (1) IL89734A (fr)
NO (1) NO177714C (fr)
PH (1) PH30960A (fr)
RU (2) RU1826970C (fr)
UA (1) UA26845C2 (fr)
ZA (1) ZA892188B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0360390A1 (fr) * 1988-07-25 1990-03-28 Glaxo Group Limited Dérivés de spirolactames
US5093127A (en) * 1989-06-02 1992-03-03 Fujisawa Pharmaceutical Co., Ltd. Preparation of fr115224 substrate for parenteral administration
FR2666335B1 (fr) 1990-09-05 1992-12-11 Sanofi Sa Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
ATE129409T1 (de) * 1990-12-21 1995-11-15 Fujisawa Pharmaceutical Co Neue verwendung von peptidderivat.
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
US5830854A (en) * 1992-12-14 1998-11-03 Merck Sharp & Dohme, Limited Method of treating cystic fibrosis using a tachykinin receptor antagonist
WO1994020126A1 (fr) * 1993-03-03 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Utilisation de peptidiques pour la fabrication d'un medicament
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2729954B1 (fr) 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
JPS6424156A (en) * 1987-07-17 1989-01-26 Yanmar Diesel Engine Co Air-fuel ratio control device for gas engine
JP2570670B2 (ja) * 1987-12-28 1997-01-08 味の素株式会社 トキソプラズマ増殖抑制剤
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
CN1037857C (zh) 1998-03-25
FI891581A0 (fi) 1989-04-03
FI891581A7 (fi) 1989-10-06
GB8807921D0 (en) 1988-05-05
GR3023353T3 (en) 1997-08-29
EP0336230A2 (fr) 1989-10-11
NO177714B (no) 1995-07-31
CA1335662C (fr) 1995-05-23
EP0336230A3 (fr) 1991-07-17
ZA892188B (en) 1989-11-29
KR890016061A (ko) 1989-11-28
NO891389L (no) 1989-10-06
KR0132567B1 (ko) 1998-04-14
JP2551142B2 (ja) 1996-11-06
EP0336230B1 (fr) 1997-02-12
FI102547B1 (fi) 1998-12-31
IL89734A (en) 1994-05-30
RU1826970C (ru) 1993-07-07
AU3239789A (en) 1989-10-12
DE68927759T2 (de) 1997-06-19
DK161789D0 (da) 1989-04-04
DE68927759D1 (de) 1997-03-27
ATE148890T1 (de) 1997-02-15
DK161789A (da) 1989-10-06
HUT49631A (en) 1989-10-30
ES2097736T3 (es) 1997-04-16
FI102547B (fi) 1998-12-31
CN1036795A (zh) 1989-11-01
JPH02204499A (ja) 1990-08-14
NO891389D0 (no) 1989-04-03
UA26845C2 (uk) 1999-12-29
HU204853B (en) 1992-02-28
AU627453B2 (en) 1992-08-27
PH30960A (en) 1997-12-23
IL89734A0 (en) 1989-09-28
RU2043365C1 (ru) 1995-09-10

Similar Documents

Publication Publication Date Title
NO904904D0 (no) Fremgangsmaate for fremstilling av en polypeptidforbindelse
AU3829089A (en) Fr901228 substance and preparation thereof
HUT53368A (en) Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them
HUT58735A (en) Process for producing pyrazolo-pyridine derivatives
FI102547B1 (fi) Menetelmä valmistaa farmakologisesti käyttökelpoista peptidiyhdistettä
IL123551A0 (en) Tricyclic erythromycin derivatives
HU901427D0 (en) Process for the preparation of ws7622 a, b, c and d
AU640241B2 (en) Ws7622a mono- or di-sulfate, process for preparation thereof and use thereof
NO174886C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
HUT59936A (en) Process for producing 10,11,12,13-tetrahydro-demicosin derivatives and pharmaceutical compositions containing them as active components
AU8692691A (en) Cyclic imino derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001